Recap: Arcturus Therapeutics Q4 Earnings

Arcturus Therapeutics ARCT reported its Q4 earnings results on Thursday, March 7, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.

Arcturus Therapeutics beat estimated earnings by 68.0%, reporting an EPS of $-0.32 versus an estimate of $-0.99.

Revenue was down $126.30 million from the same period last year.

Last quarter the company beat on EPS by $1.08 which was followed by a 16.0% increase in the share price the next day.

Here's a look at Arcturus Therapeutics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-1.69	-0.21	0.06	0.98
EPS Actual	-0.61	-1.98	0.62	4.33
Revenue Estimate	15.86M	48.50M	37.94M	72.68M
Revenue Actual	45.14M	10.52M	80.28M	160.29M

To track all earnings releases for Arcturus Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar